ALNYLAM PHARMACEUTICALS, INC.: revenue

Value{"amount": 1828292000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001178670-24-000008
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/revenue/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/cae8eab1-f3d9-4a2f-9cba-648b3bc79457

History